Clinical Trials Browser

Interventional × Lapatinib × Endocrine × Clear all

NCT00939523 2020-01-22

Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy

Phase 2 Completed

9 enrolled 11 charts

Pituitary Neoplasms, Prolactinoma